Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Elbirt

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
AIDS (London, England)|February 6, 2025
Drug resistance testing at regimen failure in individuals diagnosed with HIV-1 between 2010 and 2018 in IsraelTali Wagner, Itzchak Levy, Anat Wieder-Finesod, et al.
Plos One|March 8, 2013
Transmission patterns of HIV-subtypes A/AE versus B: inferring risk-behavior trends and treatment-efficacy limitations from viral genotypic data obtained prior to and during antiretroviral therapyBoaz Avidor, Dan Turner, Zohar Mor, et al.
HIV Research & Clinical Practice|February 12, 2025
Bictegravir/emtricitabine/tenofovir alafenamide in clinical practice for people with HIV: final 24-month effectiveness and safety outcomes in key populations in the observational BICSTaR cohortBenoit Trottier, Chia-Jui Yang, Dai Watanabe, et al.
Viruses|December 23, 2023
Factors Associated with Virological Failure in First-Line Antiretroviral Therapy in Patients Diagnosed with HIV-1 between 2010 and 2018 in IsraelTali Wagner, Itzchak Levy, Daniel Elbirt, et al.
Viruses|January 22, 2022
Epidemiology and Transmitted HIV-1 Drug Resistance among Treatment-Naïve Individuals in Israel, 2010-2018Tali Wagner, Neta S Zuckerman, Tami Halperin, et al.
AIDS (London, England)|July 24, 2019
Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in EuropeBastian Neesgaard, Annegret Pelchen-Matthews, Lene Ryom, et al.
AIDS Research and Therapy|August 6, 2022
Observational cohort study of rilpivirine (RPV) utilization in EuropeAlessandro Cozzi-Lepri, Lars Peters, Annegret Pelchen-Matthews, et al.
Plos One|January 30, 2014
Comparable long-term efficacy of Lopinavir/Ritonavir and similar drug-resistance profiles in different HIV-1 subtypesZehava Grossman, Jonathan M Schapiro, Itzchak Levy, et al.
Plos One|August 25, 2015
A Population-Structured HIV Epidemic in Israel: Roles of Risk and EthnicityZehava Grossman, Boaz Avidor, Zohar Mor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2024
Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort CollaborationErich Tusch, Lene Ryom, Annegret Pelchen-Matthews, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
AIDS (London, England)|February 6, 2025
Drug resistance testing at regimen failure in individuals diagnosed with HIV-1 between 2010 and 2018 in IsraelTali Wagner, Itzchak Levy, Anat Wieder-Finesod, et al.
Plos One|March 8, 2013
Transmission patterns of HIV-subtypes A/AE versus B: inferring risk-behavior trends and treatment-efficacy limitations from viral genotypic data obtained prior to and during antiretroviral therapyBoaz Avidor, Dan Turner, Zohar Mor, et al.
HIV Research & Clinical Practice|February 12, 2025
Bictegravir/emtricitabine/tenofovir alafenamide in clinical practice for people with HIV: final 24-month effectiveness and safety outcomes in key populations in the observational BICSTaR cohortBenoit Trottier, Chia-Jui Yang, Dai Watanabe, et al.
Viruses|December 23, 2023
Factors Associated with Virological Failure in First-Line Antiretroviral Therapy in Patients Diagnosed with HIV-1 between 2010 and 2018 in IsraelTali Wagner, Itzchak Levy, Daniel Elbirt, et al.
Viruses|January 22, 2022
Epidemiology and Transmitted HIV-1 Drug Resistance among Treatment-Naïve Individuals in Israel, 2010-2018Tali Wagner, Neta S Zuckerman, Tami Halperin, et al.
AIDS (London, England)|July 24, 2019
Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in EuropeBastian Neesgaard, Annegret Pelchen-Matthews, Lene Ryom, et al.
AIDS Research and Therapy|August 6, 2022
Observational cohort study of rilpivirine (RPV) utilization in EuropeAlessandro Cozzi-Lepri, Lars Peters, Annegret Pelchen-Matthews, et al.
Plos One|January 30, 2014
Comparable long-term efficacy of Lopinavir/Ritonavir and similar drug-resistance profiles in different HIV-1 subtypesZehava Grossman, Jonathan M Schapiro, Itzchak Levy, et al.
Plos One|August 25, 2015
A Population-Structured HIV Epidemic in Israel: Roles of Risk and EthnicityZehava Grossman, Boaz Avidor, Zohar Mor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2024
Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort CollaborationErich Tusch, Lene Ryom, Annegret Pelchen-Matthews, et al.
Pageof 8